MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-29-0001042
Instapill Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.92 Cr
▲ 11% YoY
Net loss · FY 2025
₹83.7 Cr
Net margin -82.9%
EBITDA · FY 2025
-₹24.31 Cr
EBITDA margin -24.1%
Authorised capital
₹25.58 Cr
Registered with MCA
Paid-up capital
₹18.64 Cr
Issued & subscribed
Open charges
₹232.46 Cr
Satisfied ₹190.85 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
161
Provident fund records
About Instapill Private Limited
Data last updated:
Instapill Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Tenshi Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2007PTC042337. Its GSTIN is 29AABCH8821J1ZA (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25.58 Cr and a paid-up capital of ₹18.64 Cr. It was formerly known as Higher Pharmatech Private Limited. It is led by directors including Ankit Gupta (Whole-Time Director) and Guruswamy Pendyala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 46 1st Phase KIADB Industrial Area Harohalli Kanakapura, Bangalore, Karnataka, India – 562112.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.92 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹83.7 Cr (net margin -82.9%) and EBITDA of -₹24.31 Cr (EBITDA margin -24.1%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 91% over five years.
The company has about 161 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Triphase Pharmaceuticals and Tenshi Life Sciences. As per MCA filings, the company has open charges of ₹232.46 Cr and satisfied charges of ₹190.85 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 1 case is pending. The company has 12 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹205.39 Cr; the latest was in March 2023. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Sachin Parenteral Private Limited with revenue of ₹101.7 Cr. The company has 17 MSME Form 1 returns on record between 2019 and 2024, listing 2,010 overdue payments to 108 micro and small suppliers.
Instapill Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-29-0001042). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tenshi.co.in.
Company details
CIN U24230KA2007PTC042337
Registration Number 042337
Incorporation Date 02 April 2007
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 16 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Tenshi Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-29-0001042
Name history
Instapill has undergone 2 name changes throughout its history. The company was previously known as Higher Pharmatech Private Limited, and Instapill Private Limited. The current legal name is Instapill Private Limited.
| Company Name | Status |
|---|---|
| Instapill Private Limited | Current |
| Higher Pharmatech Private Limited | Previous |
Key People
Ankit Gupta Whole-Time Director Guruswamy Pendyala Whole-Time Director Venkataraman Subramanian Iyer Director Recognitions & Rankings of Instapill
Contact details
Instapill Private Limited's registered office is in Bangalore, Karnataka. Its website is tenshi.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 46 1st Phase KIADB Industrial Area Harohalli Kanakapura, Bangalore, Karnataka, India – 562112
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Instapill Private Limited, buy the company report.
Comprehensive company report
Instapill Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Instapill operates two associated brands: Triphase Pharmaceuticals and Tenshi Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. | triphasepharma.com | |
| Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. | tenshi.co.in |
Business activity
The main business activity of Instapill is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Instapill Private Limited, buy the company report.
Financials of Instapill Private Limited
FY 2025 filings availableInstapill Private Limited reported revenue of ₹100.92 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹100.92 Cr ▲ 11%
Net loss · FY 2025
₹83.7 Cr margin -82.9%
EBITDA · FY 2025
-₹24.31 Cr margin -24.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 25%
5 years · compounded
▲ 91%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▼ 65%
5 years · compounded
▼ 10%
Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 11% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹24.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹83.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.1% | ||||
| Net Profit Margin | -82.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Instapill Private Limited, buy the company report.
Board of directors of Instapill Private Limited
Instapill has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Gupta Also directs: AI Cue Capital LLP, Dvise Medtech Private Limited, Karuna Healthcare Group Private Limited and 2 more | Whole-Time Director | 11 Feb 2025 | 1 Years 8 Months | Current |
| Venkataraman Subramanian Iyer Also directs: Areco Leafware LLP | Director | 02 Apr 2007 | 19 Years 6 Months | Current |
| Rajashri Santosh Kumar Ojha Also directs: Fermenta Biotech Limited, Raaj Gprac Private Limited | Director | 11 Feb 2025 | 1 Years 8 Months | Current |
| Gopakumar Gopalan Nair Also directs: Gnanlex Associates LLP, Gnanlex Hermeneutics Private Limited | Director | 11 Feb 2025 | 1 Years 8 Months | Current |
| Guruswamy Pendyala | Whole-Time Director | 28 Apr 2017 | 9 Years 6 Months | Current |
Peer comparison
Instapill Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sachin Parenteral Private Limited | ₹101.7 Cr (FY 2025) | 82.0% | Aligarh, Uttar Pradesh, India | |||
| Pharma Impex Laboratories Pvt Ltd | ₹101.54 Cr (FY 2024) | 12.0% | Kolkata, West Bengal, India | |||
| Samrudh Pharmaceuticals Private Limited | ₹101.47 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Nabros Pharma Private Limited | ₹101.03 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Instapill Private Limitedthis company | ₹100.92 Cr (FY 2025) | -₹83.7 Cr | -82.9% | 11.0% | 161 | Bangalore, Karnataka, India |
| Sotac Pharmaceuticals Limited | ₹100.88 Cr (FY 2025) | -3.0% | Sanand, Gujarat, India | |||
| Lake Chemicals Private Limited | ₹100.59 Cr (FY 2025) | -5.0% | Bangalore, Karnataka, India | |||
| Credo Life Sciences Private Limited | ₹100.47 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Consern Pharma Limited | ₹100.37 Cr (FY 2025) | -2.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Instapill Private Limited, buy the company report.
Auditor
Instapill Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2024 | 117366W/W-100018 |
Shareholding
The shareholding of Instapill Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Instapill Private Limited, buy the company report.
Charges & borrowings
Open charges
₹232.46 Cr
Satisfied charges
₹190.85 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101177587 | Others | ₹60 Cr | Open | |
| 13 Oct 2025 | 101177582 | Others | ₹95 Cr | Open | |
| 09 Oct 2025 | 101177584 | Others | ₹10 Cr | Open | |
| 22 Jul 2025 | 101143449 | Hdfc Bank Limited | ₹32.21 Lakh | Open | |
| 24 May 2024 | 100929265 | Hdfc Bank Limited | ₹26.81 Lakh | Open |
To see the full charge records of Instapill Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Instapill Private Limited has 12 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹205.39 Cr; the latest was in March 2023.
Total deals
12
Funding rounds
5
Secondary share transfers
3
Rights issues
2
Convertible or debt financing
1
Disclosed funding
₹205.39 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: Tenshi Pharmaceuticals Private Limited Seller: Tenshi Life Sciences Private Limited |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Tenshi Life Sciences Private Limited Seller: Six Rays Pharma Solutions LLP |
| Mar 2021 | Funding round | ₹48.67 Cr | Investors: Tenshi Life Sciences Private Limited , an individual |
| Mar 2021 | Funding round | ₹27.65 Cr | Investors: Tenshi Life Sciences Private Limited |
| Jul 2020 | Funding round | ₹16.39 Cr | Investors: Tenshi Life Sciences Private Limited |
To see the full deal history of Instapill Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Instapill Private Limited has 5 court cases on record: 3 filed by Instapill, 2 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CARBP) | Filed against the company by Cogoport Private Limited | Pending |
| Bombay High Court | Court case (CARBP) | Filed by the company against Cogoport Pvt Ltd | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.A.A.) | Filed by the company against Triphase Pharmaceuticals Private Limited and 1 other | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed by the company against M/S Triphase Pharmaceuticals Private Limited | Disposed |
| District court, MYSURU, Karnataka | Civil suit | Filed against the company | Disposed |
To see the full case history of Instapill Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Instapill Private Limited was last rated by Icra on 22 Apr 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 22 Apr 2021 |
To see the full credit ratings and regulatory alerts of Instapill Private Limited, buy the company report.
MSME payment delays
Instapill Private Limited has 17 MSME Form 1 returns on record between 2019 and 2024, listing 2,010 overdue payments to 108 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 108)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Hym Brothers | |||
| Eshwari Fabricators & Engineering | |||
| Cemil Biosciences Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Instapill Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Instapill has 2 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
2
Associated companies
Employees & EPFO
Instapill Private Limited has a workforce of 161 employees on its EPFO records as of Aug 07, 2024, across 1 active EPFO establishment.
Employee count
161
Active EPFO establishments
1
Employee growth
11.81%
GST
Instapill has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCH8821J1ZA | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Instapill Private Limited, buy the company report.
Recent activity
Instapill Private Limited has 15 board changes on record since 2007: 5 appointments and 10 cessations. The latest: Ankit Gupta was appointed as Whole-Time Director on 11 Feb 2025.
Charges
A charge registered on 09 Sep 2024 via Charge ID 100983055 with Hdfc Bank Limited was fully satisfied on 11 Dec 2025.
Charges
A charge registered on 06 Jun 2023 via Charge ID 100732161 with Hdfc Bank Limited was fully satisfied on 11 Dec 2025.
Charges
A charge registered on 17 Aug 2022 via Charge ID 100613828 with Hdfc Bank Limited was fully satisfied on 11 Dec 2025.
Charges
A charge with Others amounted to Rs. 60.00 Cr with Charge ID 101177587 was registered on 13 Oct 2025.
Charges
A charge with Others amounted to Rs. 95.00 Cr with Charge ID 101177582 was registered on 13 Oct 2025.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101177584 was registered on 09 Oct 2025.
AGM
Instapill Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records.
Charges
A charge registered on 13 Mar 2024 via Charge ID 100891049 with Others was fully satisfied on 31 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 101143449 was registered on 22 Jul 2025.
Filing
Instapill Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Ankit Gupta was appointed as Whole-Time Director.
Ceased
Chamarahalli Sundhar Krishna Iyer ceased to be Director.
29 earlier events are in the company report.
Frequently asked questions
Instapill is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 2007 (19+ years old) and is registered under CIN U24230KA2007PTC042337.
Instapill has 5 current directors:
- Ankit Gupta - Whole-Time Director
- Guruswamy Pendyala - Whole-Time Director
- Venkataraman Subramanian Iyer - Director
- Rajashri Santosh Kumar Ojha - Director
- Gopakumar Gopalan Nair - Director
The latest financial statements of Instapill on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Instapill is 29AABCH8821J1ZA, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Instapill is U24230KA2007PTC042337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Instapill has 5 court cases on record: 3 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Instapill was incorporated on 02 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
Instapill has 12 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹205.39 Cr; the latest was in March 2023.
The peers of Instapill by revenue are Sachin Parenteral Private Limited, Pharma Impex Laboratories Pvt Ltd, Samrudh Pharmaceuticals Private Limited, Nabros Pharma Private Limited, Sotac Pharmaceuticals Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ankit Gupta was appointed as Whole-Time Director on 11 Feb 2025. Chamarahalli Sundhar Krishna Iyer ceased to be Director on 11 Feb 2025. Gopakumar Gopalan Nair was appointed as Director on 11 Feb 2025. Instapill has 15 board changes on record in total.
Yes, Instapill is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-29-0001042).
Instapill has 17 MSME Form 1 returns on record between 2019 and 2024, listing 2,010 overdue payments to 108 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages